Adenocarcinoma of lung (disorder)
|
0.120 |
Biomarker
|
disease |
BEFREE |
A serial deletion of the 1.2 kb at the 5'-flanking region of the human HLJ1 gene was subcloned into a vector containing reporter gene and transfected into human lung adenocarcinoma cell line CL1-0, followed by luciferase activity assay.
|
15782117 |
2005 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Overexpression of HLJ1 can suppress cancer cell invasion in vitro.
|
15782117 |
2005 |
Tumor Cell Invasion
|
0.060 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of HLJ1 can suppress cancer cell invasion in vitro.
|
15782117 |
2005 |
Primary malignant neoplasm
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Overexpression of HLJ1 can suppress cancer cell invasion in vitro.
|
15782117 |
2005 |
Carcinoma of lung
|
0.130 |
AlteredExpression
|
disease |
BEFREE |
HLJ1 expression inhibited lung cancer cell proliferation, anchorage-independent growth, tumorigenesis, cell motility, and invasion, and slowed cell cycle progression through a novel STAT1/P21(WAF1) pathway that is independent of P53 and interferon.
|
16788156 |
2006 |
Adenocarcinoma of lung (disorder)
|
0.120 |
AlteredExpression
|
disease |
BEFREE |
We induced HLJ1 overexpression or knockdown in human lung adenocarcinoma CL1-5 cells and analyzed cell proliferation, anchorage-independent growth, in vivo tumorigenesis, cell motility, invasion, and cell cycle progression.
|
16788156 |
2006 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
We measured HLJ1 expression in tumors and adjacent normal tissues of 71 NSCLC patients by quantitative reverse transcription-polymerase chain reaction.
|
16788156 |
2006 |
Tumor Cell Invasion
|
0.060 |
Biomarker
|
phenotype |
BEFREE |
We previously identified DnaJ-like heat shock protein (HLJ1) as a gene associated with tumor invasion.
|
16788156 |
2006 |
Non-Small Cell Lung Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Loss of heterozygosity (LOH) mapping of the HLJ1 locus was analyzed in 48 paired microdissected NSCLC tumors.All statistical tests were two-sided.
|
16788156 |
2006 |
Tumor Progression
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
Here, we investigated the clinical significance of HLJ1 expression in non-small-cell lung cancer (NSCLC) patients and its role in cancer progression.
|
16788156 |
2006 |
Malignant neoplasm of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
HLJ1 expression inhibited lung cancer cell proliferation, anchorage-independent growth, tumorigenesis, cell motility, and invasion, and slowed cell cycle progression through a novel STAT1/P21(WAF1) pathway that is independent of P53 and interferon.
|
16788156 |
2006 |
Primary malignant neoplasm of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
HLJ1 expression inhibited lung cancer cell proliferation, anchorage-independent growth, tumorigenesis, cell motility, and invasion, and slowed cell cycle progression through a novel STAT1/P21(WAF1) pathway that is independent of P53 and interferon.
|
16788156 |
2006 |
Neoplasm Metastasis
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Elucidation of the regulatory mechanism of HLJ1 expression may facilitate the development of personalized therapy by inhibiting cancer cell proliferation, angiogenesis, and metastasis.
|
17510411 |
2007 |
Neoplasms
|
0.070 |
Biomarker
|
group |
BEFREE |
HLJ1 is a novel tumor and invasion suppressor that inhibits tumorigenesis and cancer metastasis.
|
17510411 |
2007 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Elucidation of the regulatory mechanism of HLJ1 expression may facilitate the development of personalized therapy by inhibiting cancer cell proliferation, angiogenesis, and metastasis.
|
17510411 |
2007 |
Tumor Cell Invasion
|
0.060 |
Biomarker
|
phenotype |
BEFREE |
HLJ1 is a novel tumor and invasion suppressor that inhibits tumorigenesis and cancer metastasis.
|
17510411 |
2007 |
Primary malignant neoplasm
|
0.060 |
AlteredExpression
|
group |
BEFREE |
Elucidation of the regulatory mechanism of HLJ1 expression may facilitate the development of personalized therapy by inhibiting cancer cell proliferation, angiogenesis, and metastasis.
|
17510411 |
2007 |
Carcinogenesis
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
HLJ1 is a novel tumor and invasion suppressor that inhibits tumorigenesis and cancer metastasis.
|
17510411 |
2007 |
Carcinoma of lung
|
0.130 |
Biomarker
|
disease |
BEFREE |
Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
|
18794131 |
2008 |
Neoplasm Metastasis
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
In this study, we found that curcumin can inhibit cancer cell invasion and metastasis through activation of the tumor suppressor DnaJ-like heat shock protein 40 (HLJ1).
|
18794131 |
2008 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that curcumin can inhibit cancer cell invasion and metastasis through activation of the tumor suppressor DnaJ-like heat shock protein 40 (HLJ1).
|
18794131 |
2008 |
Malignant Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that curcumin can inhibit cancer cell invasion and metastasis through activation of the tumor suppressor DnaJ-like heat shock protein 40 (HLJ1).
|
18794131 |
2008 |
Tumor Cell Invasion
|
0.060 |
AlteredExpression
|
phenotype |
BEFREE |
Activation of HLJ1 by curcumin further leads to up-regulation of E-cadherin and a suppression of cancer cell invasion.
|
18794131 |
2008 |
Primary malignant neoplasm
|
0.060 |
AlteredExpression
|
group |
BEFREE |
In this study, we found that curcumin can inhibit cancer cell invasion and metastasis through activation of the tumor suppressor DnaJ-like heat shock protein 40 (HLJ1).
|
18794131 |
2008 |
Malignant neoplasm of lung
|
0.030 |
Biomarker
|
disease |
BEFREE |
Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
|
18794131 |
2008 |